Dendrite Announces Third Quarter 2006 Earnings Conference Call

  
    
  
  
    
      Dendrite International, Inc. (NASDAQ: DRTE) a leading provider of 
      pharmaceutical industry solutions, today announced that it plans to 
      release its third quarter earnings after the close of market on 
      Thursday, November 2, 2006. A press release will be issued at 4 p.m. EST 
      that day, followed by a conference call at 5 p.m. EST.
    
    
      Investors may call [phone] (United States) or (973) 
      935-2987 (International) to access the conference call. In addition 
      to the call, a link to a live simulcast, which will also be available 
      for replay, will be available at www.dendrite.com 
      in the Investors' Highlights section. For a replay of the 
      conference call, investors may call [phone] (United 
      States) or [phone] (International); access code is 8018487.
    
    
      About Dendrite
    
    
      Founded in 1986, Dendrite International (NASDAQ: DRTE) enables sales, 
      marketing, clinical and compliance solutions for the global 
      pharmaceutical industry. The Company’s clients 
      are located in more than 50 countries, and include the world's top 20 
      pharmaceutical companies. For more information, please visit www.dendrite.com.
    
    
      Note: Dendrite is a registered trademark of Dendrite International, Inc.
    
    
      This document may contain forward-looking statements that may be 
      identified by such forward-looking terminology as "expect," "believe," 
      "anticipate," "will," "intend," "plan," "target," "outlook," "guidance," 
      and similar statements or variations. Such forward-looking statements 
      are based on our current expectations, estimates, assumptions and 
      projections and involve significant risks and uncertainties, including 
      risks which may result from our dependence on the pharmaceutical 
      industry; fluctuations in quarterly revenues due to lengthy sales and 
      implementation cycles for certain of our solutions; our fixed expenses 
      in relation to fluctuating revenues and variations in customers' budget 
      cycles; dependence on certain major customers; changes in demand for our 
      products and services attributable to any weakness experienced in the 
      economy or mergers, acquisitions and consolidations in the 
      pharmaceutical industry; successful and timely development and 
      introduction of new products and versions; rapid technological changes; 
      increased competition; international operations; integrating the 
      entities we acquire; our ability to effectively manage our growth; the 
      protection of our proprietary technology; our ability to compete in the 
      Internet-related products and services market; the continued demand for 
      Internet-related products and services; the ability of our third party 
      vendors to respond to technological change; our ability to maintain our 
      relationships with third-party vendors; less favorable than anticipated 
      results from strategic relationships; dependence of data solutions on 
      strategic relationships; events which may affect the U.S. and world 
      economies; and catastrophic events which could negatively affect our 
      information technology infrastructure. Other important factors that 
      should be reviewed and carefully considered are included in the 
      company's 10-K, 10-Qs, and other reports filed with the SEC. Actual 
      results may differ materially. The company assumes no obligation for 
      updating any such forward-looking statements to reflect actual results, 
      changes in assumptions or other changes affecting such forward-looking 
      statements and the information provided in this press release should not 
      be construed as updating, modifying or confirming the company's most 
      recent financial outlook or guidance.
    
  
Dendrite International, Inc. (NASDAQ: DRTE) a leading provider of
pharmaceutical industry solutions, today announced that it plans to
release its third quarter earnings after the close of market on
Thursday, November 2, 2006. A press release will be issued at 4 p.m.
EST that day, followed by a conference call at 5 p.m. EST.

   Investors may call [phone] (United States) or (973)
935-2987 (International) to access the conference call. In addition to
the call, a link to a live simulcast, which will also be available for
replay, will be available at www.dendrite.com in the Investors'
Highlights section. For a replay of the conference call, investors may
call [phone] (United States) or [phone] (International);
access code is 8018487.

   About Dendrite

   Founded in 1986, Dendrite International (NASDAQ: DRTE) enables
sales, marketing, clinical and compliance solutions for the global
pharmaceutical industry. The Company's clients are located in more
than 50 countries, and include the world's top 20 pharmaceutical
companies. For more information, please visit www.dendrite.com.

   Note: Dendrite is a registered trademark of Dendrite
International, Inc.

   This document may contain forward-looking statements that may be
identified by such forward-looking terminology as "expect," "believe,"
"anticipate," "will," "intend," "plan," "target," "outlook,"
"guidance," and similar statements or variations. Such forward-looking
statements are based on our current expectations, estimates,
assumptions and projections and involve significant risks and
uncertainties, including risks which may result from our dependence on
the pharmaceutical industry; fluctuations in quarterly revenues due to
lengthy sales and implementation cycles for certain of our solutions;
our fixed expenses in relation to fluctuating revenues and variations
in customers' budget cycles; dependence on certain major customers;
changes in demand for our products and services attributable to any
weakness experienced in the economy or mergers, acquisitions and
consolidations in the pharmaceutical industry; successful and timely
development and introduction of new products and versions; rapid
technological changes; increased competition; international
operations; integrating the entities we acquire; our ability to
effectively manage our growth; the protection of our proprietary
technology; our ability to compete in the Internet-related products
and services market; the continued demand for Internet-related
products and services; the ability of our third party vendors to
respond to technological change; our ability to maintain our
relationships with third-party vendors; less favorable than
anticipated results from strategic relationships; dependence of data
solutions on strategic relationships; events which may affect the U.S.
and world economies; and catastrophic events which could negatively
affect our information technology infrastructure. Other important
factors that should be reviewed and carefully considered are included
in the company's 10-K, 10-Qs, and other reports filed with the SEC.
Actual results may differ materially. The company assumes no
obligation for updating any such forward-looking statements to reflect
actual results, changes in assumptions or other changes affecting such
forward-looking statements and the information provided in this press
release should not be construed as updating, modifying or confirming
the company's most recent financial outlook or guidance.